Latest Overdiagnosis Stories
BOULDER, Col., March 6, 2015 /PRNewswire/ -- NEBA Health announces today that Brain and Behavior has published validation results for the first biomarker cleared by FDA to assist a
Task Force says harms of PSA screening outweigh the benefits OTTAWA, Oct.
An accompanying editorial says this study largely confirms what is already known - that the benefits of breast screening "are modest at best" – and calls for women to be given balanced information including the screening harms of overdiagnosis, psychological stress, and high healthcare costs.
Medicare Committee Decision Leaves Medicare-Reliant At Risk WASHINGTON, May 2, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation President Andrea Ferris today commented on the Medicare
The government is putting pressure on commissioners, and in turn general practitioners, to make more diagnoses of dementia, but no analysis has been done to assess the harm that these targets could cause.
A comprehensive review of 50 year's worth of international studies assessing the benefits and harms of mammography screening suggests that the benefits of the screening are often overestimated, while harms are underestimated.
Nation's leading independent radiology practice network not alone in expressing frustration over misleading findings. (PRWEB) March 11, 2014 In response
Nomogram aims to enable informed decision-making and personalized treatment SEATTLE, Jan.
Using a nomogram that incorporates age, Gleason score, and prostate-specific antigen (PSA) level at diagnosis, individual risks that a screen-detected prostate cancer has been overdiagnosed can be estimated.
Data from the National Lung Cancer Screening Trial (NLST)—conducted by the American College of Radiology Imaging Network and National Cancer Institute Lung Screening Study—provided researchers the opportunity to investigate the probability that a cancer detected with screening low-dose computed tomography (LDCT) would not have progressed to become life threatening.
- Large; stout; burly.